Its the mail on Sunday15 Dec 2017 13:16
Traded on Aim, Microsaic’s shares are 46½p and should increase substantially as the company acquires new customers and cements its reputation in the mass spectrometry market, an industry worth more than £3billion a year globally.
Microsaic’s revenues last year were £1.2million and the group is loss-making, as it invests in research and sales. However, it is backed by top institutions such as BlackRock and Fidelity, and entrepreneur Nigel Wray has a large stake in the business.